Due to health issues, this site is no longer maintained and will be shut down shortly.

ADILW Adial Pharmaceuticals Inc Warrant Expiring 2/2024

The warrants are exercisable upon issuance at a price of $4.0625 per share of common stock, subject to adjustment in certain circumstances, and will expire on February 26, 2024.  This security was issued by Adial Pharmaceuticals Inc, whose common stock symbol is ADIL.

Their auditors issued a going concern opinion on their December 31, 2019 financial statements, expressing substantial doubt that they could continue as an ongoing business for the next twelve months.   

$0.05  +0.01 (31.54%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Warrants
Category3:  Operating Companies
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/27/2018
Outstanding shares:  2,133,750
Average volume:  3,307
Market cap:   $166,433
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy